5,0
30 nov 2024
Huidige werknemer, meer dan 3 jaar
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Great culture, benefits, strong portfolio and nice people. Strong payer coverage for all products.
Minpunten
Some growing pains, some favoritism, like most companies. Large geographical responsibilities. Chinese name in USA marketplace . Lack of contracting opportunities for small and mid size oncology providers.